Skip to main content
. 2026 Sep 23;14(10):2146. doi: 10.3390/biomedicines14102146
AFP Alpha-fetoprotein
ALBI Albumin–bilirubin
BCLC Barcelona Clinic Liver Cancer
CI Confidence interval
CLEIA Chemiluminescent enzyme immunoassay
CMIA Chemiluminescent microparticle immunoassay
DCP Des-γ-carboxy prothrombin
EIA Enzyme immunoassay
GPC-3 Glypican-3
HBV Hepatitis B virus
HCC Hepatocellular carcinoma
HCV Hepatitis C virus
HDV Hepatitis D virus
HR Hazard ratio
MASLD Metabolic dysfunction-associated steatotic liver disease
MELD Model for End-Stage Liver Disease
OS Overall survival
PIVKA-II Protein induced by vitamin K absence-II
VEGF Vascular endothelial growth factor